In vivo targeting and multimodal imaging of cerebral amyloid-β aggregates using hybrid GdF3 nanoparticles.
Lerouge F, Ong E, Rositi H, Mpambani F, Berner LP, Bolbos R, Olivier C, Peyrin F, Apputukan VK, Monnereau C, Andraud C, Chaput F, Berthezène Y, Braun B, Jucker M, Åslund AK, Nyström S, Hammarström P, R Nilsson KP, Lindgren M, Wiart M, Chauveau F, Parola S.
Lerouge F, et al. Among authors: hammarstrom p.
Nanomedicine (Lond). 2022 Dec;17(29):2173-2187. doi: 10.2217/nnm-2022-0252. Epub 2023 Mar 17.
Nanomedicine (Lond). 2022.
PMID: 36927004